These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2033679)

  • 1. Serum ferritin: a tumor marker for renal cell carcinoma.
    Essen A; Ozen H; Ayhan A; Ergen A; Tasar C; Remzi F
    J Urol; 1991 Jun; 145(6):1134-7. PubMed ID: 2033679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum ferritin as a clinical marker for renal cell carcinoma: influence of tumor volume.
    Partin AW; Criley SR; Steiner MS; Hsieh K; Simons JW; Lumadue J; Carter HB; Marshall FF
    Urology; 1995 Feb; 45(2):211-7. PubMed ID: 7855968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum ferritin in renal cell carcinoma: effect of tumor size, volume grade, and stage.
    Singh KJ; Singh SK; Suri A; Vijjan V; Goswami AK; Khullar M
    Indian J Cancer; 2005; 42(4):197-200. PubMed ID: 16391438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum ferritin determination: is it useful in the early diagnosis of renal carcinoma?].
    D'Addessi A; Racioppi M; Zappacosta B; Fanasca A; De Michele T; Alcini E
    Arch Ital Urol Androl; 1997 Dec; 69(5):283-6. PubMed ID: 9477611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum ferritin as a clinical marker for renal cell carcinoma: influence of tumor size and volume.
    Kirkali Z; Güzelsoy M; Mungan MU; Kirkali G; Yörükoglu K
    Urol Int; 1999; 62(1):21-5. PubMed ID: 10436426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between serum ferritin levels and tumour status in patients with renal cell carcinoma.
    Miyata Y; Koga S; Nishikido M; Hayashi T; Kanetake H
    BJU Int; 2001 Dec; 88(9):974-7. PubMed ID: 11851623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferritin: a tumor marker expressed by renal cell carcinoma.
    Kirkali Z; Esen AA; Kirkali G; Güner G
    Eur Urol; 1995; 28(2):131-4. PubMed ID: 8529738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of serum ferritin in patients with renal cell carcinoma.
    Ozen H; Uygur C; Sahin A; Tekgül S; Ergen A; Remzi D
    Urology; 1995 Oct; 46(4):494-8. PubMed ID: 7571217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour-associated trypsin inhibitor and renal cell carcinoma.
    Meria P; Toubert ME; Cussenot O; Bassi S; Janssen T; Desgrandchamps F; Cortesse A; Schlageter MH; Teillac P; Le Duc A
    Eur Urol; 1995; 27(3):223-6. PubMed ID: 7601186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum immunosuppressive acidic protein in renal cell carcinoma.
    Ueda T
    Urol Res; 1986; 14(2):101-3. PubMed ID: 3727211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative high levels of serum vascular endothelial growth factor are a prognostic marker for poor outcome after surgical treatment of renal cell carcinoma.
    Guðbrandsdottir G; Hjelle KM; Frugård J; Bostad L; Aarstad HJ; Beisland C
    Scand J Urol; 2015; 49(5):388-94. PubMed ID: 25773545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum immunosuppressive acidic protein and natural killer cell activity in patients with metastatic renal cell carcinoma before and after nephrectomy.
    Fujikawa K; Matsui Y; Miura K; Kobayashi T; Oka H; Fukuzawa S; Takeuchi H
    J Urol; 2000 Sep; 164(3 Pt 1):673-5. PubMed ID: 10953123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basic fibroblast growth factor as a candidate tumor marker for renal cell carcinoma.
    Fujimoto K; Ichimori Y; Yamaguchi H; Arai K; Futami T; Ozono S; Hirao Y; Kakizoe T; Terada M; Okajima E
    Jpn J Cancer Res; 1995 Feb; 86(2):182-6. PubMed ID: 7730142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of gamma-enolase as a tumor marker for renal cell carcinoma.
    Takashi M; Haimoto H; Tanaka J; Murase T; Kato K
    J Urol; 1989 Apr; 141(4):830-4. PubMed ID: 2648028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The usefulness of serum levels of CEA, CA 50, and ferritin in the management of renal cell cancer.
    Kokociñska D; Rajchel K; Nalewajka E; Zagalski K
    J Environ Pathol Toxicol Oncol; 1996; 15(2-4):279-81. PubMed ID: 9216822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive values of acute phase reactants, basic fetoprotein, and immunosuppressive acidic protein for staging and survival in renal cell carcinoma.
    Miyata Y; Koga S; Nishikido M; Noguchi M; Kanda S; Hayashi T; Saito Y; Kanetake H
    Urology; 2001 Aug; 58(2):161-4. PubMed ID: 11489689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal masses--to treat or not to treat? If that is the question are contemporary biomarkers the answer?
    Uzzo RG
    J Urol; 2008 Aug; 180(2):433-4. PubMed ID: 18550098
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased serum levels of vascular endothelial growth factor in patients with renal cell carcinoma.
    Sato K; Tsuchiya N; Sasaki R; Shimoda N; Satoh S; Ogawa O; Kato T
    Jpn J Cancer Res; 1999 Aug; 90(8):874-9. PubMed ID: 10543260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Significance of Pregnancy-associated Plasma Protein a Serum Concentration in Clear Cell Renal Cell Carcinoma.
    Cechova M; Chocholaty M; Zima T; Babjuk M; Kalousova M
    Anticancer Res; 2019 Jun; 39(6):3249-3253. PubMed ID: 31177175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue polypeptide-specific antigen in renal cell carcinoma.
    Höbarth K; Hallas A; Kramer G; Aulitzky W; Gomahr A; Steiner G; Marberger M
    Eur Urol; 1996; 30(1):89-95. PubMed ID: 8854074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.